272 related articles for article (PubMed ID: 34618539)
1. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Maas SLN; Stichel D; Hielscher T; Sievers P; Berghoff AS; Schrimpf D; Sill M; Euskirchen P; Blume C; Patel A; Dogan H; Reuss D; Dohmen H; Stein M; Reinhardt A; Suwala AK; Wefers AK; Baumgarten P; Ricklefs F; Rushing EJ; Bewerunge-Hudler M; Ketter R; Schittenhelm J; Jaunmuktane Z; Leu S; Greenway FEA; Bridges LR; Jones T; Grady C; Serrano J; Golfinos J; Sen C; Mawrin C; Jungk C; Hänggi D; Westphal M; Lamszus K; Etminan N; Jungwirth G; Herold-Mende C; Unterberg A; Harter PN; Wirsching HG; Neidert MC; Ratliff M; Platten M; Snuderl M; Aldape KD; Brandner S; Hench J; Frank S; Pfister SM; Jones DTW; Reifenberger G; Acker T; Wick W; Weller M; Preusser M; von Deimling A; Sahm F;
J Clin Oncol; 2021 Dec; 39(34):3839-3852. PubMed ID: 34618539
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Cosmas Z; Franke H; Roohani S; Wasilewksi D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
[TBL] [Abstract][Full Text] [Related]
4. Clinical implementation of integrated molecular-morphologic risk prediction for meningioma.
Hielscher T; Sill M; Sievers P; Stichel D; Brandner S; Jones DTW; von Deimling A; Sahm F; Maas SLN
Brain Pathol; 2023 May; 33(3):e13132. PubMed ID: 36377252
[TBL] [Abstract][Full Text] [Related]
5. A molecularly integrated grade for meningioma.
Driver J; Hoffman SE; Tavakol S; Woodward E; Maury EA; Bhave V; Greenwald NF; Nassiri F; Aldape K; Zadeh G; Choudhury A; Vasudevan HN; Magill ST; Raleigh DR; Abedalthagafi M; Aizer AA; Alexander BM; Ligon KL; Reardon DA; Wen PY; Al-Mefty O; Ligon AH; Dubuc AM; Beroukhim R; Claus EB; Dunn IF; Santagata S; Bi WL
Neuro Oncol; 2022 May; 24(5):796-808. PubMed ID: 34508644
[TBL] [Abstract][Full Text] [Related]
6. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
Front Oncol; 2022; 12():846232. PubMed ID: 35299730
[TBL] [Abstract][Full Text] [Related]
7. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
[TBL] [Abstract][Full Text] [Related]
8. Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY; Hinz F; Maas SLN; Anil G; Sievers P; Conde-Lopez C; Lischalk J; Rauh S; Eichkorn T; Regnery S; Bauer L; Held T; Meixner E; Lang K; Hörner-Rieber J; Herfarth K; Jones D; Pfister SM; Jungk C; Unterberg A; Wick W; von Deimling A; Debus J; Sahm F; König L
Neurooncol Adv; 2023; 5(1):vdad059. PubMed ID: 37293256
[TBL] [Abstract][Full Text] [Related]
9. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F; Mamatjan Y; Suppiah S; Badhiwala JH; Mansouri S; Karimi S; Saarela O; Poisson L; Gepfner-Tuma I; Schittenhelm J; Ng HK; Noushmehr H; Harter P; Baumgarten P; Weller M; Preusser M; Herold-Mende C; Tatagiba M; Tabatabai G; Sahm F; von Deimling A; ; Zadeh G; Aldape KD
Neuro Oncol; 2019 Jul; 21(7):901-910. PubMed ID: 31158293
[TBL] [Abstract][Full Text] [Related]
11. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
[TBL] [Abstract][Full Text] [Related]
12. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
14. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification and grading of meningioma.
Nasrallah MP; Aldape KD
J Neurooncol; 2023 Jan; 161(2):373-381. PubMed ID: 36802047
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
[TBL] [Abstract][Full Text] [Related]
19. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Raleigh D; Chen W; Choudhury A; Youngblood M; Polley MY; Lucas CH; Mirchia K; Maas S; Suwala A; Won M; Bayley J; Harmanci A; Harmanci A; Klisch T; Nguyen M; Vasudevan H; McCortney K; Yu T; Bhave V; Lam TC; Pu J; Leung G; Chang J; Perlow H; Palmer J; Haberler C; Berghoff A; Preusser M; Nicolaides T; Mawrin C; Agnihotri S; Resnick A; Rood B; Chew J; Young J; Boreta L; Braunstein S; Schulte J; Butowski N; Santagata S; Spetzler D; Bush NAO; Villanueva-Meyer J; Chandler J; Solomon D; Rogers C; Pugh S; Mehta M; Sneed P; Berger M; Horbinski C; McDermott M; Perry A; Bi W; Patel A; Sahm F; Magill S
Res Sq; 2023 Mar; ():. PubMed ID: 36993741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
